571 related articles for article (PubMed ID: 29674135)
1. Mean HbA
Forbes A; Murrells T; Mulnier H; Sinclair AJ
Lancet Diabetes Endocrinol; 2018 Jun; 6(6):476-486. PubMed ID: 29674135
[TBL] [Abstract][Full Text] [Related]
2. Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetes.
Ghouse J; Isaksen JL; Skov MW; Lind B; Svendsen JH; Kanters JK; Olesen MS; Holst AG; Nielsen JB
Diabetes Obes Metab; 2020 Feb; 22(2):231-242. PubMed ID: 31596048
[TBL] [Abstract][Full Text] [Related]
3. Associations Between Mean HbA1c, HbA1c Variability, and Both Mortality and Macrovascular Complications in Patients with Diabetes Mellitus: A Registry-Based Cohort Study.
Tan JK; Lim GH; Mohamed Salim NN; Chia SY; Thumboo J; Bee YM
Clin Epidemiol; 2023; 15():137-149. PubMed ID: 36721457
[TBL] [Abstract][Full Text] [Related]
4. Early and ongoing stable glycaemic control is associated with a reduction in major adverse cardiovascular events in people with type 2 diabetes: A primary care cohort study.
Whyte MB; Joy M; Hinton W; McGovern A; Hoang U; van Vlymen J; Ferreira F; Mount J; Munro N; de Lusignan S
Diabetes Obes Metab; 2022 Jul; 24(7):1310-1318. PubMed ID: 35373891
[TBL] [Abstract][Full Text] [Related]
5. Glycaemic control and mortality in older people with type 2 diabetes: The Fremantle Diabetes Study Phase II.
Bruce DG; Davis WA; Davis TME
Diabetes Obes Metab; 2018 Dec; 20(12):2852-2859. PubMed ID: 30003670
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study.
Holman N; Knighton P; Kar P; O'Keefe J; Curley M; Weaver A; Barron E; Bakhai C; Khunti K; Wareham NJ; Sattar N; Young B; Valabhji J
Lancet Diabetes Endocrinol; 2020 Oct; 8(10):823-833. PubMed ID: 32798471
[TBL] [Abstract][Full Text] [Related]
7. Glycaemic markers and all-cause mortality in older adults with and without diabetes: the Atherosclerosis Risk in Communities (ARIC) study.
Rooney MR; Tang O; Pankow JS; Selvin E
Diabetologia; 2021 Feb; 64(2):339-348. PubMed ID: 32990802
[TBL] [Abstract][Full Text] [Related]
8. Haemoglobin A1c and 5-year all-cause mortality in French type 2 diabetic patients aged 70 years and older: The GERODIAB observational cohort.
Doucet J; Verny C; Balkau B; Scheen AJ; Bauduceau B
Diabetes Metab; 2018 Dec; 44(6):465-472. PubMed ID: 29859993
[TBL] [Abstract][Full Text] [Related]
9. Mortality in Individuals Aged 80 and Older with Type 2 Diabetes Mellitus in Relation to Glycosylated Hemoglobin, Blood Pressure, and Total Cholesterol.
Hamada S; Gulliford MC
J Am Geriatr Soc; 2016 Jul; 64(7):1425-31. PubMed ID: 27295278
[TBL] [Abstract][Full Text] [Related]
10. Sodium-glucose co-transporter-2 inhibitors, the latest residents on the block: Impact on glycaemic control at a general practice level in England.
Heald AH; Fryer AA; Anderson SG; Livingston M; Lunt M; Davies M; Moreno GYC; Gadsby R; Young RJ; Stedman M
Diabetes Obes Metab; 2018 Jul; 20(7):1659-1669. PubMed ID: 29516618
[TBL] [Abstract][Full Text] [Related]
11. Glycaemic control trends in people with type 1 diabetes in Scotland 2004-2016.
Mair C; Wulaningsih W; Jeyam A; McGurnaghan S; Blackbourn L; Kennon B; Leese G; Lindsay R; McCrimmon RJ; McKnight J; Petrie JR; Sattar N; Wild SH; Conway N; Craigie I; Robertson K; Bath L; McKeigue PM; Colhoun HM;
Diabetologia; 2019 Aug; 62(8):1375-1384. PubMed ID: 31104095
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial.
Dejgaard TF; Frandsen CS; Hansen TS; Almdal T; Urhammer S; Pedersen-Bjergaard U; Jensen T; Jensen AK; Holst JJ; Tarnow L; Knop FK; Madsbad S; Andersen HU
Lancet Diabetes Endocrinol; 2016 Mar; 4(3):221-232. PubMed ID: 26656289
[TBL] [Abstract][Full Text] [Related]
13. Impact of insulin initiation on glycaemic variability and glucose profiles in a primary healthcare Type 2 diabetes cohort: analysis of continuous glucose monitoring data from the INITIATION study.
Manski-Nankervis J; Yates CJ; Blackberry I; Furler J; Ginnivan L; Cohen N; Jenkins A; Vasanthakumar S; Gorelik A; Young D; Best J; O'Neal D
Diabet Med; 2016 Jun; 33(6):803-11. PubMed ID: 26435033
[TBL] [Abstract][Full Text] [Related]
14. Rates of glycaemic deterioration in a real-world population with type 2 diabetes.
Donnelly LA; Zhou K; Doney ASF; Jennison C; Franks PW; Pearson ER
Diabetologia; 2018 Mar; 61(3):607-615. PubMed ID: 29260253
[TBL] [Abstract][Full Text] [Related]
15. HbA1c variability predicts cardiovascular complications in type 2 diabetes regardless of being at glycemic target.
Ceriello A; Lucisano G; Prattichizzo F; La Grotta R; Franzén S; Svensson AM; Eliasson B; Nicolucci A
Cardiovasc Diabetol; 2022 Jan; 21(1):13. PubMed ID: 35073913
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of people with high visit-to-visit glycaemic variability in Type 2 diabetes.
Noyes JD; Soto-Pedre E; Donnelly LA; Pearson ER
Diabet Med; 2018 Feb; 35(2):262-269. PubMed ID: 28755478
[TBL] [Abstract][Full Text] [Related]
17. Visit-to-Visit Variability of Hemoglobin A
Ghouse J; Skov MW; Kanters JK; Lind B; Isaksen JL; Blanche P; Haunsø S; Køber L; Svendsen JH; Olesen MS; Holst AG; Gerds TA; Nielsen JB
Diabetes Care; 2019 Jan; 42(1):134-141. PubMed ID: 30352898
[TBL] [Abstract][Full Text] [Related]
18. Contemporary risk estimates of three HbA
Skrtic S; Cabrera C; Olsson M; Schnecke V; Lind M
Heart; 2017 Mar; 103(5):353-358. PubMed ID: 27647169
[TBL] [Abstract][Full Text] [Related]
19. Effect of diabetes duration and glycaemic control on 14-year cause-specific mortality in Mexican adults: a blood-based prospective cohort study.
Herrington WG; Alegre-Díaz J; Wade R; Gnatiuc L; Ramirez-Reyes R; Hill M; Solano-Sánchez M; Baigent C; Lewington S; Collins R; Tapia-Conyer R; Peto R; Kuri-Morales P; Emberson JR
Lancet Diabetes Endocrinol; 2018 Jun; 6(6):455-463. PubMed ID: 29567074
[TBL] [Abstract][Full Text] [Related]
20. Establishing an evidence base for frequency of monitoring glycated haemoglobin levels in patients with Type 2 diabetes: projections of effectiveness from a regression model.
Oke JL; Stevens RJ; Gaitskell K; Farmer AJ
Diabet Med; 2012 Feb; 29(2):266-71. PubMed ID: 21838767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
